AVITA Medical, Inc. (RCEL) has a MoatMap StockRank of 44/100 based on Quality (29/100), Value (50/100), and Momentum (52/100) factor scores. The current signal is HOLD. AVITA Medical is a regenerative medicine company. While its RECELL system has clinical merit, the company is currently unprofitable, faces high adoption hurdles, and lacks the established moat and steady cash flows of a quality compounder.
AVITA Medical, Inc. is a regenerative medicine company focused on skin repair and reconstruction, primarily known for its RECELL System. The RECELL System uses a patient's own skin to create a regenerative suspension, enabling rapid treatment of burns, scars, and other skin defects. This proprietary technology provides a significant competitive advantage in the advanced wound care and aesthetic markets, offering a unique and effective solution for complex skin injuries.
| Price | $4.12 |
| Market Cap | $135M |
| P/E (Forward) | -5.32 |
| Price/Book | -8.00 |
| Gross Margin | 81.4% |
| Operating Margin | -45.7% |
| Revenue Growth | 4.0% |
| Free Cash Flow | $-18M |
AVITA Medical, Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).